Correction: Elevated carbonic anhydrase-1 in the aqueous humor in diabetic macular edema: associations between inflammatory cytokines and retinal vascular dysfunction - Scorecard - MDSpire

Correction: Elevated carbonic anhydrase-1 in the aqueous humor in diabetic macular edema: associations between inflammatory cytokines and retinal vascular dysfunction

  • By

  • Jie Liu

  • Jingxin Zeng

  • Pengfei Ren

  • Xiao Ke

  • Fang Lu

  • Xiaoshuang Jiang

  • June 11, 2026

  • 0 min

Share

Clinical Scorecard: Correction: Increased levels of carbonic anhydrase-1 in the aqueous humor of patients with diabetic macular edema: links to inflammatory cytokines and retinal vascular impairment

At a Glance

CategoryDetail
Condition
Key MechanismsIncreased levels of carbonic anhydrase-1 associated with inflammatory cytokines and retinal vascular impairment (source needed).
Target Population
Care Setting

Key Highlights

  • add

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

        Risks

          Patient & Prescribing Data

          Increased carbonic anhydrase-1 levels may indicate inflammatory processes (source needed).

          Clinical Best Practices

            Related Resources & Content

            Original Source(s)

            Correction: Elevated carbonic anhydrase-1 in the aqueous humor in diabetic macular edema: associations between inflammatory cytokines and retinal vascular dysfunction

            • by Jie Liu, Jingxin Zeng, Pengfei Ren, Xiao Ke, Fang Lu, Xiaoshuang Jiang

            • June 11, 2026

            Related Content

            Assessment of Hypertensive Retinopathy Severity and Associated Factors in Adult Patients at Ophthalmic Clinics in Northern Ethiopia: A Multicenter Cross-Sectional Analysis

            Ultra-Widefield Color Fundus Photography in Diabetic Retinopathy: From Panretinal Assessment to Multimodal Integration

            Retinal Imaging Model Aids CAD Detection

            Fundus-based model showed moderate-to-good accuracy and improved performance when combined with clinical risk factors in a high-risk cohort